Simulations Plus (NASDAQ:SLP) Trading Down 8% – What’s Next?

Simulations Plus, Inc. (NASDAQ:SLP)’s share price dropped 8% during trading on Thursday . The company traded as low as $33.22 and last traded at $33.02. Approximately 108,838 shares changed hands during trading, a decline of 58% from the average daily volume of 258,353 shares. The stock had previously closed at $35.90.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on SLP. StockNews.com lowered shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. Stephens began coverage on shares of Simulations Plus in a research note on Friday, November 15th. They issued an “overweight” rating and a $39.00 target price for the company. Finally, KeyCorp increased their price target on Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $49.40.

Simulations Plus Stock Performance

The company has a market capitalization of $638.26 million, a PE ratio of 79.43 and a beta of 0.83. The business has a fifty day moving average price of $31.69 and a 200 day moving average price of $32.19.

Insiders Place Their Bets

In other news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the sale, the director now owns 3,402,584 shares of the company’s stock, valued at $115,381,623.44. This represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 19.40% of the stock is owned by insiders.

Hedge Funds Weigh In On Simulations Plus

Institutional investors and hedge funds have recently bought and sold shares of the stock. First Horizon Advisors Inc. raised its stake in shares of Simulations Plus by 82.6% during the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock valued at $26,000 after purchasing an additional 370 shares during the period. Jones Financial Companies Lllp increased its stake in Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock worth $34,000 after buying an additional 427 shares during the period. Johnson Financial Group Inc. acquired a new position in Simulations Plus in the 4th quarter worth $39,000. Quantbot Technologies LP purchased a new stake in shares of Simulations Plus during the third quarter worth about $59,000. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Simulations Plus by 42.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company’s stock valued at $72,000 after buying an additional 764 shares during the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.